Fighting Heart Disease Through Email Reminders
A recent study shows that simple email reminders can keep those with heart disease healthy and compliant without additional disease management programs
New Haven, CT - September 21, 2009 - Controlling high cholesterol levels and blood pressure is the first and most vital step in treating patients with coronary artery disease. Lower cholesterol in those who have been diagnosed with heart disease leads to significantly better long-term outcomes and higher quality of life. However, although it has been proven that lowering elevated cholesterol levels and high blood pressure save lives, heart disease patients often do not receive proper care and treatment in the wake of a coronary artery disease diagnosis.
In order to shed light on how to improve treatment patterns after patient discharge using only limited resources, the Clinical Pharmacy Cardiac Risk Service (CPCRS) Study Group conducted a two-year study that measured the effects of simple electronic medical reminders on patient cholesterol levels, high blood pressure, and overall outcomes. In the study, Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management, researchers followed 421 heart disease patients and their cholesterol levels. While some patients continued enrollment in a disease management program, others received only usual physician care and electronic medical reminder emails.
The study's results, which were published in the American Journal of Managed Care's August issue, found that the majority of those receiving email reminder emails in addition to usual medical care from their primary care physicians were able to control their blood pressure and cholesterol just as well as those enrolled in a disease management program that required more resources. Specifically, 91 percent of those in a disease management program successfully controlled their cholesterol levels while 93 percent of those receiving only reminders kept their cholesterol low. At the same time, 75 percent of those in a disease management program controlled their high blood pressure while 84 percent of those only receiving email reminders controlled their high blood pressure.
"This study shows that although there are, indeed, a large number of ways to help patients adhere to their medication routines and appointment schedules, some interventions may be easier and more cost-effective then more complex models," said Kevin Aniskovich, Chief Executive at Intelecare. "While we at Intelecare maintain the benefit of a robust program that surrounds the patient, at a time when there is a delicate balance between dollars and outcomes, we would be remiss not to consider equally effective solutions that demonstrate successful patient outcomes - for both the patient and the healthcare system."
To read the study in full, please visit: http://www.ajmc.com
Established in 2005, Intelecare Compliance Solutions is a privately owned healthcare information technology company that provides an array of practical tools and services promoting medical adherence. With 84 percent of patients reporting forgetfulness as the major cause of non-compliance, and with the healthcare system suffering over $300 billion in costs annually due to non-compliance, Intelecare's solutions enable patients and caregivers alike to keep track of medications, doses, and doctor's appointments through the phone, mobile devices, and email - all while keeping simplicity, practicality, and innovation at the heart of its developments.
Aside from direct to patient services, Intelecare provides a suite of scalable services for insurers, employers, retail pharmacies, non-profit organizations and pharmaceutical manufacturers. Currently supporting millions of covered lives, Intelecare is dedicated to finding functional solutions to the widespread issue of medical non-compliance that work the way people live.
Intelecare in the News: Founder and CEO named to Top 100 people in Life-Sciences industry.
Click here to read more.
*Intelecare and the Intelecare motion logo are registered trademarks of Intelecare Compliance Solutions, Inc. All other trademarks are the property of their respective owners.